ABUS vs. QTUM

Last updated Aug 1, 2026

ABUS (Arbutus Biopharma Corporation) is a stock, while QTUM (Defiance Quantum ETF) is Technology Equities fund tracking the BlueStar Machine Learning and Quantum Computing Index. Over the past 5 years, ABUS returned 10.04%/yr vs 24.56%/yr for QTUM. Their 0.32 correlation means their historical movements had little consistent relationship.

Performance

ABUS vs. QTUM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arbutus Biopharma Corporation (ABUS) and Defiance Quantum ETF (QTUM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ABUS achieves a -9.77% return, which is significantly lower than QTUM's 29.28% return.

ABUS

• 1D: -1.59%
• 1M: -10.88%
• 6M: 5.08%
• YTD: -9.77%
• 1Y: 32.72%
• 3Y*: 25.80%
• 5Y*: 10.04%
• 10Y*: 0.57%
• ALL TIME*: -7.94%

QTUM

• 1D: 0.67%
• 1M: -8.88%
• 6M: 22.33%
• YTD: 29.28%
• 1Y: 57.72%
• 3Y*: 39.51%
• 5Y*: 24.56%
• 10Y*: —
• ALL TIME*: 25.62%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ABUS Arbutus Biopharma Corporation	$5.92M	$9.50M	$8.90M
QTUM Defiance Quantum ETF	$54.21M	$61.13M	$111.15M

ABUS vs. QTUM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
ABUS Arbutus Biopharma Corporation	-9.77%	47.09%	30.80%	7.30%	-40.10%	9.58%	27.70%	-27.42%	-62.63%
QTUM Defiance Quantum ETF	29.28%	36.65%	50.54%	39.86%	-28.80%	35.18%	42.05%	47.99%	-19.44%

Correlation

The correlation between ABUS and QTUM is 0.28, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.28
Correlation (3Y) Balances recent behavior with more history.	0.27
Correlation (5Y) Shows whether the relationship held over a longer period.	0.33
Correlation (All Time) Calculated using the full available price history since Sep 5, 2018	0.32

Return for Risk

ABUS vs. QTUM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ABUS

ABUS Risk / Return Rank: 67
ABUS Sharpe Ratio Rank: 68
ABUS Sortino Ratio Rank: 63
ABUS Omega Ratio Rank: 62
ABUS Calmar Ratio Rank: 71
ABUS Martin Ratio Rank: 71

QTUM

QTUM Risk / Return Rank: 74
QTUM Sharpe Ratio Rank: 77
QTUM Sortino Ratio Rank: 71
QTUM Omega Ratio Rank: 70
QTUM Calmar Ratio Rank: 74
QTUM Martin Ratio Rank: 76

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ABUS vs. QTUM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arbutus Biopharma Corporation (ABUS) and Defiance Quantum ETF (QTUM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ABUS	QTUM	Difference
Sharpe ratio: Return per unit of total volatility	0.69	1.75	-1.06
Sortino ratio: Return per unit of downside risk	1.18	2.29	-1.11
Omega ratio: Gain probability vs. loss probability	1.15	1.29	-0.14
Calmar ratio: Return relative to maximum drawdown	1.26	2.57	-1.32
Martin ratio: Return relative to average drawdown	3.04	9.41	-6.37

ABUS vs. QTUM - Sharpe Ratio Comparison

The current ABUS Sharpe Ratio is 0.69, which is lower than the QTUM Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of ABUS and QTUM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ABUS vs. QTUM - Drawdown Comparison

The maximum ABUS drawdown since its inception was -92.96%, which is greater than QTUM's maximum drawdown of -38.45%. Use the drawdown chart below to compare losses from any high point for ABUS and QTUM.

Drawdown Indicators

	ABUS	QTUM	Difference
Max Drawdown Largest peak-to-trough decline	-92.96%	-38.45%	-54.51%
Max Drawdown (1Y) Largest decline over 1 year	-25.86%	-21.51%	-4.35%
Max Drawdown (3Y) Largest decline over 3 years	-36.84%	-25.39%	-11.45%
Max Drawdown (5Y) Largest decline over 5 years	-63.42%	-38.45%	-24.97%
Max Drawdown (10Y) Largest decline over 10 years	-92.96%	—	—
Current Drawdown Current decline from peak	-64.86%	-16.16%	-48.70%
Average Drawdown Average peak-to-trough decline	-68.97%	-8.27%	-60.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.66%	5.87%	+4.79%

Volatility

ABUS vs. QTUM - Volatility Comparison

Arbutus Biopharma Corporation (ABUS) has a higher volatility of 13.94% compared to Defiance Quantum ETF (QTUM) at 11.38%. This indicates that ABUS's price experiences larger fluctuations and is considered to be riskier than QTUM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ABUS	QTUM	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.94%	11.38%	+2.56%
Volatility (6M) Calculated over the trailing 6-month period	32.09%	26.47%	+5.62%
Volatility (1Y) Calculated over the trailing 1-year period	47.05%	31.67%	+15.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	54.45%	27.69%	+26.76%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.41%	27.69%	+57.72%

Dividends

ABUS vs. QTUM - Dividend Comparison

ABUS has not paid dividends to shareholders, while QTUM's dividend yield for the trailing twelve months is around 0.83%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
ABUS Arbutus Biopharma Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
QTUM Defiance Quantum ETF	0.83%	1.01%	0.61%	0.81%	1.46%	0.48%	0.42%	0.61%	0.21%

Frequently Asked Questions

Can I hold both ABUS and QTUM in my portfolio?

ABUS and QTUM have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ABUS or QTUM?

ABUS has higher volatility (13.94%) compared to QTUM (11.38%). In terms of maximum drawdown, ABUS dropped -92.96% vs QTUM's -38.45%.

Which has better risk-adjusted returns?

QTUM currently has the higher Sharpe Ratio (1.75 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.